89bio, Inc.
ETNB
$8.45
$0.273.30%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.61% | -210.76% | 7.18% | -28.45% | -15.87% |
| Total Depreciation and Amortization | 12.50% | -33.33% | 33.33% | -43.75% | 60.00% |
| Total Amortization of Deferred Charges | 86.29% | 4.17% | 3.70% | -9.50% | -25.10% |
| Total Other Non-Cash Items | -23.34% | 51.46% | 22.25% | 1.47% | 0.13% |
| Change in Net Operating Assets | -739.17% | 94.94% | -272.13% | 175.19% | 90.45% |
| Cash from Operations | 16.36% | -137.65% | -53.99% | -15.83% | -12.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 329.64% | -131.02% | 134.86% | -25.55% | -266.05% |
| Cash from Investing | 329.47% | -131.02% | 134.86% | -25.54% | -266.06% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 451.85% | -11.18% | 21.30% | -85.84% | 138,507.69% |
| Repurchase of Common Stock | 98.01% | -2,217.95% | 97.69% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 154.15% | -- | -- |
| Cash from Financing | 310.97% | 18.71% | 32.95% | -87.03% | 11,057.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.68% | -2,155.97% | 94.57% | -253.48% | 890.52% |
